SwiftSync
Pioneering the future of cardiac care with innovative dual-chamber pacing technology.
General Information
BounceWatch is an independent company data service, not affiliated with SwiftSync. To contact SwiftSync, visit swiftsync.net.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does SwiftSync compare?
A PDF of SwiftSync and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting SwiftSync soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is SwiftSync on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About SwiftSync
Business keywords: medtech, cardiac care, dual-chamber pacing technology, temporary cardiac pacing, arrhythmia management, surgical procedures, emergency medicine, clinical trials, FDA approval, commercial sales, innovative technology, cardiology, electrical cardiac stimulation, disposable catheters
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | $1.50M | - |
|
05 Feb 2024 |
| Series A | $3.50M | 2 |
|
14 May 2021 |
SwiftSync Alternatives & Competitors
View All Alternatives
On a mission to revolutionize arrhythmia care.
Dedicated to natural breathing by empowering patients to wean off mechanical ventilation and breathe...
Lesion Creation at the Speed of Light
FAQ About SwiftSync
Source: BounceWatch company record for SwiftSync, https://bouncewatch.com/company/swiftsync, updated 27 December 2024. When citing, please name BounceWatch and link this page.
